Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06816329 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Stress Dynamics and Familial Risk for Depression in Female Adolescents

StatusRecruiting
PhaseNot applicable
Started2025-10-15
View on ClinicalTrials.gov ↗

Amendment history

2025-10-22
minor
Study Status v3
Start dateestimated 2025-09-23→confirmed 2025-10-15
2025-09-23
notable
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v2
Trial statusNot Yet Recruiting→Recruiting
Start date2025-08-01→2025-09-23
Study sites0→1
2025-05-05
minor
Study Status v1
Start date2025-04-01→2025-08-01
2025-02-03
minor
Original filing
53 trials monitored
See 1 trial at risk
2,976 trials monitored
See 162 trials at risk
Stress and a parental history of major depressive disorder (MDD) are among the strongest risk factors for future development of MDD. Studies have shown that having a parental history of MDD may be associated with behavioral, psychophysiological, and hormonal responses to stress that are associated with poorer stress coping. . Adolescence is a vulnerable developmental window linked to increased MDD risk, especially for females, as rates of MDD surge relative to males. Despite the central role of stress in MDD onset, little is known about the brain mechanisms underlying stress responses in susceptible female adolescents at high familial risk for MDD. Also, it is unclear how stress-related brain network alterations may relate to "real-world" maladaptive stress responses and whether these stress-related brain network changes are predictive of future depression onset. We will fulfill these research gaps by combining neuroimaging with intensive longitudinal tracking of depressive symptomology as well as behavioral and physiological responses to "real world" stress using smartphone and smartwatch technology. Elucidating these neural mechanisms may aid in the discovery of MDD biomarkers that could identify youth at greatest risk for future MDD development and lead to earlier intervention efforts.
Trial Details
NCT Number NCT06816329
Lead Sponsor Mclean Hospital
Collaborators: National Institute of Mental Health (NIMH)
Conditions Major Depressive Disorder
Enrollment 148 participants
Start Date 2025-10-15
Primary Completion 2030-03-31 (estimated)
Study Completion 2030-03-31 (estimated)
Updated on ClinicalTrials.gov 2025-10-23